Katsuhiko Hatazawa
Direktor/Vorstandsmitglied bei Spera Pharma, Inc.
Profil
Katsuhiko Hatazawa currently works at Jitsubo Co., Ltd., as Director and Spera Pharma, Inc., as Director.
Aktive Positionen von Katsuhiko Hatazawa
Unternehmen | Position | Beginn |
---|---|---|
Spera Pharma, Inc.
Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan. | Direktor/Vorstandsmitglied | - |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Spera Pharma, Inc.
Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan. | Health Technology |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |